Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted April 20, 2006 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        


Cuba and India have become leaders in today’s biotechnology, said Indian Finance Minister P. Chidambaram on Tuesday during the opening of a modern institution for the production of humanized monoclonal h-R3 antibodies.

The official noted the importance of the joint enterprise Biocon Biopharmaceutical, created to produce and market the product.

Chidambaram also expressed the gratitude of the Indian people and government for Cuba’s assistance to earthquake victims in neighboring Pakistan.

Doctors Agustin Lage, director of the Cuban Center of Molecular Immunology and Kiran Mazumder, Biocon president, chaired the opening ceremony.

Lage confirmed that the clinical trials carried out on people affected by head and neck neoplasias and treated with h-R3 humanized monoclonal antibody evolve favorably.

Juan Carretero, the Cuban ambassador to India, called it a memorable day for all those involved in the project and especially for those like Cuban President Fidel Castro who had the vision to develop biotechnology.

Find biotechnology on Amazon

Would you like to add more information?

Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
We recommend this AirBnB Food and Drink Experience... Cuban flavors: Food, Rum and Cigars
Images of Cuba
Hotel Inglaterra in Havana
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review

Member of the Association for the Study of the Cuban Economy